Filing Details

Accession Number:
0001127602-20-030840
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-08 16:23:38
Reporting Period:
2020-12-04
Accepted Time:
2020-12-08 16:23:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Bausch Health Companies Inc. BHC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1674278 D. William Humphries 400 Somerset Corporate Boulevard
Bridgewater NJ 08807
President, Ortho-Dermatologics No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2020-12-04 114,055 $14.38 349,090 No 4 M Direct
Common Shares, No Par Value Disposition 2020-12-04 114,055 $19.87 235,035 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares, No Par Value Non-qualified Stock Options (right To Purchase) Disposition 2020-12-04 114,055 $0.00 114,055 $14.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-03-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.80 to $19.82 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote.
  2. The options vest in equal installments on each of the first three anniversaries of the date of grant.